Grassegger A, Höpfl R
Clin Exp Dermatol. 2004 Nov;29(6):584-8. doi: 10.1111/j.1365-2230.2004.01652.x.
Interferon (IFN)-gamma is considered a key cytokine of innate and adaptive immunity playing pivotal roles in host defence against microbial pathogens and tumours, and exerts profound antiproliferative and antifibrotic effects. In this review we discuss applications and perspectives of IFN-gamma in clinical dermatology, such as papillomavirus and bacterial infections, tumours, atopic dermatitis, and fibrotic conditions such as scleroderma and postradiation fibrosis. Moreover, we give a summary of the pharmacologic properties including main side effects and potential risk factors of IFN-gamma therapy. Although former enthusiasm for IFN-gamma (e.g. in atopic dermatitis) has subsided, this cytokine might remain a promising tool (and target) in clinical dermatology, due to its central immunobiologic functions, better characterization of its kinetics in diseases facilitating optimized treatment schedules, and successful applications in fibrotic conditions such as scleroderma, idiopathic pulmonary and skin postradiation fibrosis.
干扰素(IFN)-γ被认为是先天性和适应性免疫的关键细胞因子,在宿主抵御微生物病原体和肿瘤方面发挥着关键作用,并具有显著的抗增殖和抗纤维化作用。在本综述中,我们讨论了IFN-γ在临床皮肤科的应用和前景,如乳头瘤病毒和细菌感染、肿瘤、特应性皮炎以及诸如硬皮病和放射后纤维化等纤维化疾病。此外,我们总结了IFN-γ治疗的药理学特性,包括主要副作用和潜在风险因素。尽管之前对IFN-γ(如在特应性皮炎中)的热情已经消退,但由于其核心免疫生物学功能、在疾病中对其动力学的更好表征有助于优化治疗方案,以及在硬皮病、特发性肺纤维化和皮肤放射后纤维化等纤维化疾病中的成功应用,这种细胞因子在临床皮肤科可能仍然是一种有前景的工具(和靶点)。